The clinical utility of a novel blood-based multi-transcriptome assay for the diagnosis of neuroendocrine tumors of the gastrointestinal tract.
1] Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA  Wren Laboratories, Branford, Connecticut, USA.
Wren Laboratories, Branford, Connecticut, USA.
Division of Nuclear Medicine, European Institute of Oncology (IEO), Milan, Italy.
Section of Digestive Diseases, Yale University, New Haven, Connecticut, USA.
- Published Article
The American Journal of Gastroenterology
Nature Publishing Group
- Publication Date
Aug 01, 2015
This study demonstrates that a blood-based multianalyte NET gene transcript measurement of well-differentiated small intestinal and pancreatic neuroendocrine tumor disease is sensitive and specific and outperforms the current monoanalyte diagnostic strategy of plasma CgA measurement.
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 01/13/2018 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/26032155